EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study

Anders Myhre Vaage iD, Trygve Holmøy iD, Jesper Dahl iD, Hein Stigum, Haakon E Meyer iD, Ola Nakken iD

European Journal of Neurology · 2025-03 · 32 (3)

DOI: 10.1111/ene.70095 ↗

At a glance

Kohortenstudie in European Journal of Neurology, published online on 2025-03-04. Written by Anders Myhre Vaage and 5 co-authors. Institution: Department of Neurology, Akershus University Hospital, Lørenskog, Norway. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Cited 8 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: ALS Norway, Helse Sør-Øst RHF.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Dyslipidemia is common in amyotrophic lateral sclerosis (ALS). Statin use has been associated with both favorable and poor prognoses. We assessed whether statin use affects ALS survival.

Methods

We linked four Norwegian health surveys (1972–2003) with mandatory national registries to obtain information on premorbid health, ALS diagnosis, and death. Using the Norwegian Prescribed Drug Registry, we identified participants who had dispensed statins pre‐ and post‐diagnosis. We first compared pre‐diagnosis statin discontinuation rates between ALS patients and matched controls. Flexible parametric models were then fitted to estimate the relationship between statin use and survival time in ALS, using restricted mean survival time and hazard ratio (HR) as effect measures.

Results

A total of 524 patients (43% female) with ALS were included. Mean time from ALS diagnosis to death or end of study was 2.0 (SD 2.1) years. A substantial proportion of statin users (21%) discontinued statins during the year leading up to diagnosis. This group was characterized by poorer ALS prognosis compared to those adhering to statins and were included as statin users in our analysis. After adjusting for sex, age, birth year, riluzole use and premorbid smoking status, body mass index, and total cholesterol levels, statin use was not associated with ALS survival. The estimated mean survival difference comparing statin users to non‐users was 0.74 (95% CI −5.98 to 7.47) months, corresponding to a HR of 0.97 (95% CI 0.77–1.23).

Conclusion

Statin use was not associated with ALS survival, suggesting that statins should not routinely be discontinued in ALS.

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisHydroxymethylglutaryl-CoA Reductase InhibitorsHumansFemaleMaleMiddle AgedNorwayAgedCohort StudiesRegistriesAdult

Author keywords

amyotrophic lateral sclerosiscohort studieshydroxymethylglutaryl‐CoA reductase inhibitorsstatinssurvival

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Authors and institutions

  • Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.
  • Department of Physical Health and Ageing, Norwegian Institute of Public Health, Oslo, Norway.

ORCID profiles: Anders Myhre Vaage, Trygve Holmøy, Jesper Dahl, Haakon E Meyer, Ola Nakken

Funding

  • ALS Norway
  • Helse Sør-Øst RHF

Cite

APA

Vaage, A. M., Holmøy, T., Dahl, J., Stigum, H., Meyer, H. E., & Nakken, O. (2025). Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study. European Journal of Neurology, 32(3). https://doi.org/10.1111/ene.70095

Vancouver

Vaage AM, Holmøy T, Dahl J, Stigum H, Meyer HE, Nakken O. Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study. European Journal of Neurology. 2025;32(3). doi:10.1111/ene.70095

BibTeX
@article{Vaage2025,
  author = {Vaage, Anders Myhre and Holmøy, Trygve and Dahl, Jesper and Stigum, Hein and Meyer, Haakon E and Nakken, Ola},
  title = {Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population‐Based Cohort Study},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {3},
  doi = {10.1111/ene.70095}
}
Start for free →